FDA Adverse Event Malfunction Summary report: N

BD KIESTRA¿ IDENTIFA

MDR report key: 20887263 · Received December 9, 2024

Report

Report Number
3010141591-2024-00008
Event Type
Malfunction
Date Received
December 9, 2024
Date of Event
November 30, 2024
Report Date
July 29, 2025
Manufacturer
BD KIESTRA LAB AUTOMATION
Product Code
QBN
UDI-DI
00382904440633
PMA / PMN Number
K191964
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D2. ADDITIONAL MEDICAL DEVICE TYPE: QQV. COMMON DEVICE NAME: AUTOMATED SYSTEM FOR SAMPLE PREPARATION AND IDENTIFICATION OF MICROORGANISMS FROM CULTURED ISOLATES BY MASS SPECTROMETRY G5. ADDITIONAL 510K: K222563. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: THIS STATEMENT IS TO SUMMARIZE THE INVESTIGATION OF A COMPLAINT INVOLVING THE BD KIESTRA IDENTIFA. ACCORDING TO THE INFORMATION PROVIDED, THE CUSTOMER REPORTED THAT THE MALDI SYSTEM GAVE INCORRECT BACTERIAL IDENTIFICATIONS AFTER THE TARGET PLATE WAS REMOVED FROM THE IDENTIFA SYSTEM. THESE MISIDENTIFICATIONS WERE CONFIRMED BY COMPARING THE MALDI RESULTS WITH MANUAL VERIFICATION USING THE VITEK SYSTEM, WHICH PROVIDED THE CORRECT BACTERIAL STRAINS. DURING THE INVESTIGATION, THE FIELD SERVICE ENGINEER (FSE) CONFIRMED THAT THE MALDI SYSTEM HAD PREVIOUSLY PRODUCED INCORRECT RESULTS FOR SEVERAL ISOLATES. THE FSE PERFORMED MAINTENANCE ON THE DEVICE. UPON RE-EVALUATION, THE ISSUE COULD NOT BE REPRODUCED, AND NO NEW OCCURRENCES WERE REPORTED. BASED ON THIS, THE CASE WAS CLOSED. FOLLOWING THIS ACTION, NO FURTHER ISSUES WERE ENCOUNTERED. BASED ON THE INVESTIGATION, THIS CASE HAS BEEN ASSESSED AS CONFIRMED FOR A BD QUALITY ISSUE. NO NEW TRENDS, RISKS, OR HAZARDS WERE IDENTIFIED AS A RESULT OF THIS COMPLAINT. THE ISSUE IN THIS COMPLAINT DOES NOT REQUIRE THE INITIATION OF A CORRECTIVE AND PREVENTATIVE ACTION (CAPA). A DESIGN HISTORY RECORD (DHR) REVIEW IS NOT REQUIRED FOR THIS COMPLAINT. THE COMPLAINT WAS EVALUATED VIA OTHER ELEMENTS OF THE INVESTIGATION. THE RESULTS OF THIS EVALUATION HAVE NOT IDENTIFIED ANY NEW HAZARDS, NEW RISKS, OR SPECIFIC TRENDS. BD QUALITY WILL CONTINUE TO CLOSELY MONITOR TRENDS ASSOCIATED WITH THIS ISSUE.

Description of Event or Problem · 0

IT WAS REPORTED THAT FOUR SPECIMENS THAT WERE PREPARED ON THE BD KIESTRA¿ IDENTIFA GAVE FALSE IDENTIFICATION RESULTS: ENTEROCOCCI WAS IDENTIFIED AS STAPHYLOCOCCUS. ENTEROCOCCI WAS IDENTIFIED AS ECOLI. PROTEUS WAS IDENTIFIED AS STAPH. HEMOLYTICUS. E. COLI WAS IDENTIFIED AS STR. CONSTELLATUS THERE WAS NO REPORT OF PATIENT IMPACT.

Description of Event or Problem · 0

IT WAS REPORTED THAT FOUR SPECIMENS THAT WERE PREPARED ON THE BD KIESTRA¿ IDENTIFA GAVE FALSE IDENTIFICATION RESULTS: ENTEROCOCCI WAS IDENTIFIED AS STAPHYLOCOCCUS ENTEROCOCCI WAS IDENTIFIED AS ECOLI PROTEUS WAS IDENTIFIED AS STAPH. HEMOLYTICUS E. COLI WAS IDENTIFIED AS STR. CONSTELLATUS THERE WAS NO REPORT OF PATIENT IMPACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2534783 BD KIESTRA¿ IDENTIFA SEE H11 QBN BD KIESTRA LAB AUTOMATION 00382904440633

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown